A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and

Authors :: Darielys, Santana-Mederos
Rocmira, Perez-Nicado
Yanet, Climent
Laura, Rodriguez
Belinda Sanchez, Ramirez
Sonia, Perez-Rodriguez
Meybi, Rodriguez
Claudia, Labrada
Tays, Hernandez
Marianniz, Diaz
Ivette, Orosa
Ubel, Ramirez
Reynaldo, Oliva
Raine, Garrido
Felix, Cardoso
Mario, Landys
Roselyn, Martinez
Humberto, Gonzalez
Tamara, Hernandez
Rolando, Ochoa-Azze
Jose L, Perez
Juliet, Enriquez
Nibaldo, Gonzalez
Yenicet, Infante
Luis A, Espinosa
Yassel, Ramos
Luis Javier, González
Carmen, Valenzuela
Ana Victoria, Casadesus
Briandy, Fernandez
Gertrudis, Rojas
Beatriz, Pérez-Massón
Yaima, Tundidor
Ernesto, Bermudez
Claudia A, Plasencia
Tammy, Boggiano
Eduardo, Ojito
Fabrizio, Chiodo
Sonsire, Fernandez
Françoise, Paquet
Cheng, Fang
Guang-Wu, Chen
Daniel G, Rivera
Yury, Valdes-Balbin
Dagmar, Garcia-Rivera
Vicente, Verez Bencomo
Source :: RSC chemical biology. 3(2)
Publication Year :: 2021
Abstract: SARS-CoV-2 infection is mediated by the interaction of the spike glycoprotein trimer

Tools